Stockscreener 앱 받기
105.66
5.23%
5.26
시간 외 거래:
105.35
-0.31
-0.29%
전일 마감가:
$100.40
열려 있는:
$100.73
하루 거래량:
19.22M
Relative Volume:
1.48
시가총액:
$262.25B
수익:
$63.90B
순이익/손실:
$19.05B
주가수익비율:
13.98
EPS:
7.5596
순현금흐름:
$13.05B
1주 성능:
+9.57%
1개월 성능:
+20.76%
6개월 성능:
+36.19%
1년 성능:
+4.44%
1일 변동 폭
$100.70
$105.84
1주일 범위
$93.90
$105.84
52주 변동 폭
$73.31
$105.84
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
126 EAST LINCOLN AVENUE, RAHWAY, NJ
MRK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
105.66 | 249.20B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,109.94 | 957.81B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
206.68 | 496.44B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
231.81 | 405.63B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
130.26 | 242.80B | 54.45B | 14.42B | 17.15B | 7.333 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-10-13 | 재개 | Citigroup | Neutral |
| 2025-09-17 | 다운그레이드 | Berenberg | Buy → Hold |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Merck & Co., Inc. $MRK Shares Acquired by Waterloo Capital L.P. - MarketBeat
Vestor Capital LLC Sells 5,350 Shares of Merck & Co., Inc. $MRK - MarketBeat
Manchester Capital Management LLC Sells 3,180 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. (NYSE:MRK) Shares Edge Higher After Health Care Sector Coverage - Kalkine Media
Merck & Co., Inc. $MRK Shares Bought by RiverFront Investment Group LLC - MarketBeat
Jaffetilchin Investment Partners LLC Sells 10,298 Shares of Merck & Co., Inc. $MRK - MarketBeat
Global Retirement Partners LLC Buys New Shares in Merck & Co., Inc. $MRK - MarketBeat
Immuno Oncology Assays Market- By Type InSphero Inc., Merck & - openPR.com
CreativeOne Wealth LLC Boosts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Edmond DE Rothschild Holding S.A. Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Associated Banc Corp Has $8.35 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck (NYSE:MRK) S&P 500 Today Shows Pharma-Sector Growth - Kalkine Media
Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight - GlobeNewswire Inc.
MRK: Wells Fargo Upgrades Merck & Co to Overweight with New Pric - GuruFocus
Merck & Co., Inc. (NYSE:MRK) Upgraded at Wells Fargo & Company - MarketBeat
Merck & Co., Inc. $MRK Holdings Cut by Steward Partners Investment Advisory LLC - MarketBeat
Quadcap Wealth Management LLC Sells 5,535 Shares of Merck & Co., Inc. $MRK - MarketBeat
Summit Global Investments Buys 66,743 Shares of Merck & Co., Inc. $MRK - MarketBeat
Wells Fargo Upgrades Merck & Co. to Overweight From Equalweight, Adjusts PT to $125 From $90 - MarketScreener
Edgar Lomax Co. VA Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Ameritas Investment Partners Inc. - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Q3 EPS Estimate for Merck & Co., Inc. Boosted by Analyst - MarketBeat
Sierra Summit Advisors LLC Acquires 8,213 Shares of Merck & Co., Inc. $MRK - MarketBeat
Prudential Financial Inc. Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Shakespeare Wealth Management LLC Trims Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Nemes Rush Group LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Private Management Group Inc. - MarketBeat
Magnetar Financial LLC Buys 28,172 Shares of Merck & Co., Inc. $MRK - MarketBeat
Coldstream Capital Management Inc. Has $8.67 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Charles Schwab Investment Management Inc. Has $4.26 Billion Holdings in Merck & Co., Inc. $MRK - MarketBeat
Boston Research & Management Inc. Grows Position in Merck & Co., Inc. $MRK - MarketBeat
American Century Companies Inc. Has $298.63 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Richard W. Paul & Associates LLC Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
2,982 Shares in Merck & Co., Inc. $MRK Purchased by New World Advisors LLC - MarketBeat
Rhumbline Advisers Sells 383,775 Shares of Merck & Co., Inc. $MRK - MarketBeat
Mufg Securities Americas Inc. Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Evelyn Partners Investment Management LLP Increases Position in Merck & Co., Inc. $MRK - MarketBeat
Merck urges shareholders to reject Tutanota 'mini-tender' offer - Seeking Alpha
Hillsdale Investment Management Inc. Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Neo Ivy Capital Management - MarketBeat
Camden National Bank Has $8.99 Million Position in Merck & Co., Inc. $MRK - MarketBeat
4,800 Shares in Merck & Co., Inc. $MRK Purchased by Catalyst Funds Management Pty Ltd - MarketBeat
Merck Recommends Rejection of Tutanota’s “Mini-Tender” Offer - Markets Financial Content
Merck gets FDA nod for Keytruda/Padcev combo in bladder cancer - Seeking Alpha
Why Are Shares of Merck Up Today? - Benzinga
Merck Keytruda versions OK'd in U.S. for bladder cancer (MRK) - Seeking Alpha
Mediolanum International Funds Ltd Has $51.46 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Legal & General Group Plc Cuts Stake in Merck & Co., Inc. $MRK - MarketBeat
Journey Strategic Wealth LLC Purchases 6,930 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Willis Investment Counsel - MarketBeat
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.94%
자본화:
|
볼륨(24시간):